PMC:7597510 / 58-1012
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 499-509 | Body_part | denotes | lower limb | http://purl.org/sig/ont/fma/fma7184 |
T2 | 552-560 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T3 | 680-688 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 505-509 | Body_part | denotes | limb | http://purl.obolibrary.org/obo/UBERON_0002101 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T3 | 28-51 | Disease | denotes | Guillain-Barré syndrome | http://purl.obolibrary.org/obo/MONDO_0016218 |
T4 | 53-56 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T5 | 74-82 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T6 | 85-94 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T7 | 163-171 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T8 | 174-183 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T9 | 316-319 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T10 | 462-470 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T11 | 473-482 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T12 | 491-494 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T13 | 810-818 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T14 | 821-830 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T15 | 913-916 | Disease | denotes | GBS | http://purl.obolibrary.org/obo/MONDO_0016218 |
T16 | 933-941 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T17 | 944-953 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 105-109 | http://purl.obolibrary.org/obo/CLO_0001599 | denotes | A 54 |
T2 | 188-194 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
T3 | 505-509 | http://www.ebi.ac.uk/efo/EFO_0000876 | denotes | limb |
T4 | 561-566 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
15 | 119-124 | Species | denotes | woman | Tax:9606 |
16 | 289-296 | Species | denotes | patient | Tax:9606 |
17 | 448-456 | Species | denotes | patients | Tax:9606 |
18 | 796-804 | Species | denotes | patients | Tax:9606 |
19 | 74-94 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
20 | 135-156 | Disease | denotes | neurological symptoms | MESH:D009422 |
21 | 163-183 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
22 | 462-482 | Disease | denotes | SARS-CoV-2-infection | MESH:C000657245 |
23 | 700-723 | Disease | denotes | microvascular disorders | MESH:D017566 |
24 | 731-758 | Disease | denotes | vascular endothelial damage | MESH:D057772 |
25 | 771-792 | Disease | denotes | neurological symptoms | MESH:D009422 |
26 | 810-830 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
27 | 933-953 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 680-695 | Phenotype | denotes | cytokine storms | http://purl.obolibrary.org/obo/HP_0033041 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 0-104 | Sentence | denotes | We report the first case of Guillain-Barré syndrome (GBS) associated with SARS-CoV-2 infection in Japan. |
T4 | 105-184 | Sentence | denotes | A 54-year-old woman developed neurological symptoms after SARS-CoV-2 infection. |
T5 | 185-284 | Sentence | denotes | We tested for various antiganglioside antibodies, that had not been investigated in previous cases. |
T6 | 285-421 | Sentence | denotes | The patient was diagnosed with GBS based on neurological and electrophysiological findings; no antiganglioside antibodies were detected. |
T7 | 422-581 | Sentence | denotes | In previous reports, most patients with SARS-CoV-2-infection-related GBS had lower limb predominant symptoms, and antiganglioside antibody tests were negative. |
T8 | 582-831 | Sentence | denotes | Our findings support the notion that non-immune abnormalities such as hyperinflammation following cytokine storms and microvascular disorders due to vascular endothelial damage may lead to neurological symptoms in patients with SARS-CoV-2 infection. |
T9 | 832-954 | Sentence | denotes | Our case further highlights the need for careful diagnosis in suspected cases of GBS associated with SARS-CoV-2 infection. |